LLY Financial Facts
Cost of sales, operating expenses, and other-net: 4.22BDividends paid per share: 0.51
See Full Income Statement
Less accumulated depreciation: -8.99B
Total current liabilities: 8.27B
See Full Balance Sheet
Eli Lilly (LLY) Earnings
|
Expand Research on LLY
| Next EPS Date | 8/7/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +8.3% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -2.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/30/26  |
Q126 | N/A | $7.25 | N/A | N/A | $17.61B | = | N/A | N/A | ||
| 2/4/26 | Q425 | $7.54 | $7.20 | +$0.34 | $19.3B | $17.87B | = |  | | Details | |
| 10/30/25 | Q325 | $7.02 | $5.89 | +$1.13 | $17.6B | $16.07B | = | | | Details | |
| 8/7/25 | Q225 | $6.31 | $5.59 | +$0.72 | $15.56B | $14.67B | = | | | Details | |
| 5/1/25 | Q125 | $3.34 | $3.46 | -$0.12 | $12.73B | $12.72B | = | | | Details | |
| 2/6/25 | Q424 | $5.32 | $5.30 | +$0.02 | $13.53B | $13.78B | = | | | Details | |
| 10/30/24 | Q324 | $1.18 | $1.45 | -$0.27 | $11.44B | $12.09B | = | | | Details | |
| 8/8/24 | Q224 | $3.92 | $2.75 | +$1.17 | $11.3B | $10B | = | | | Details |
